American International Group Inc. Has $9.56 Million Stock Holdings in Shockwave Medical, Inc. (NASDAQ:SWAV)

American International Group Inc. trimmed its position in Shockwave Medical, Inc. (NASDAQ:SWAV) by 3.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 50,149 shares of the company’s stock after selling 1,948 shares during the period. American International Group Inc. owned approximately 0.14% of Shockwave Medical worth $9,556,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of SWAV. Janney Montgomery Scott LLC raised its position in shares of Shockwave Medical by 200.8% in the 3rd quarter. Janney Montgomery Scott LLC now owns 6,098 shares of the company’s stock valued at $1,214,000 after acquiring an additional 4,071 shares during the period. HighTower Advisors LLC raised its position in shares of Shockwave Medical by 24.9% in the 3rd quarter. HighTower Advisors LLC now owns 2,500 shares of the company’s stock valued at $501,000 after acquiring an additional 498 shares during the period. DekaBank Deutsche Girozentrale acquired a new stake in shares of Shockwave Medical in the 3rd quarter valued at approximately $133,000. QRG Capital Management Inc. acquired a new stake in shares of Shockwave Medical in the 3rd quarter valued at approximately $942,000. Finally, Envestnet Portfolio Solutions Inc. acquired a new stake in shares of Shockwave Medical in the 3rd quarter valued at approximately $204,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

SWAV has been the topic of several research analyst reports. Morgan Stanley restated an “equal weight” rating and set a $335.00 target price (up from $285.00) on shares of Shockwave Medical in a report on Monday, April 8th. Needham & Company LLC restated a “hold” rating on shares of Shockwave Medical in a report on Friday, April 5th. Canaccord Genuity Group restated a “hold” rating and set a $335.00 target price (up from $263.00) on shares of Shockwave Medical in a report on Friday, April 5th. CL King restated a “neutral” rating on shares of Shockwave Medical in a report on Monday, April 8th. Finally, Wolfe Research restated a “peer perform” rating on shares of Shockwave Medical in a report on Friday, April 5th. Ten research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $309.11.

Insider Transactions at Shockwave Medical

In other news, insider Isaac Zacharias sold 4,000 shares of Shockwave Medical stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $287.67, for a total transaction of $1,150,680.00. Following the completion of the sale, the insider now owns 56,818 shares of the company’s stock, valued at $16,344,834.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Laura Francis sold 1,500 shares of Shockwave Medical stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $300.00, for a total transaction of $450,000.00. Following the completion of the sale, the director now owns 3,551 shares of the company’s stock, valued at $1,065,300. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Isaac Zacharias sold 4,000 shares of Shockwave Medical stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $287.67, for a total value of $1,150,680.00. Following the sale, the insider now directly owns 56,818 shares of the company’s stock, valued at approximately $16,344,834.06. The disclosure for this sale can be found here. Insiders own 3.40% of the company’s stock.

Shockwave Medical Stock Performance

SWAV stock opened at $334.75 on Wednesday. The company has a debt-to-equity ratio of 0.97, a current ratio of 13.81 and a quick ratio of 12.61. The company has a fifty day moving average price of $331.53 and a two-hundred day moving average price of $271.17. Shockwave Medical, Inc. has a one year low of $157.00 and a one year high of $334.90. The stock has a market cap of $12.57 billion, a price-to-earnings ratio of 78.21, a price-to-earnings-growth ratio of 2.43 and a beta of 0.88.

Shockwave Medical (NASDAQ:SWAV) last posted its earnings results on Monday, May 6th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.99 by $0.45. Shockwave Medical had a return on equity of 24.79% and a net margin of 20.75%. The company had revenue of $218.80 million during the quarter, compared to the consensus estimate of $207.69 million. During the same quarter last year, the firm earned $1.03 earnings per share. The company’s revenue was up 35.8% on a year-over-year basis. Equities analysts anticipate that Shockwave Medical, Inc. will post 5.05 EPS for the current year.

About Shockwave Medical

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.